Last night I had a dream:
(AP REUTERS)
In a monumental announcement today, the World Health Organization declared that Viracept is unequivically a cure for the AIDS virus. Every AIDS researcher in the world joined in the announcement that Viracept would, within three months, eradicate the disease from the globe. A spokesman from the NIH was quoted: "Forget the triple cocktail, a single dose of Viracept is all anyone needs to cure this dread disease."
Supporting this proclamation, latest IMS data confirms that Viracept has captured 100% of the market for all drugs administered to AIDS patients worldwide in the latest reporting period.
In a second blockbuster announcement, the American Cancer Society proclaimed clinical trails ended for the cancer drug TM-Q and declared a cure for cancer. "Our work is done here," stated a Society official. "Thanks to Agouron, cancer as we know it no longer exists"
Completing the startling medical Trifecta, the Center for Disease Control in Atlanta announced that the FDA had agreed to forego clinical trials for Agouron's rhinovirus drug and approve it for immediate marketing. CDC officials predict the end of the common cold within 12 months.
Agouron President and CEO, Peter Johnson, reported earnings for the latest quarter of $278 per share, easily eclipsing high-end First Call estimates of .44.
In response to these announcements and dramatic earnings, every brokerage house on Wall Street upgraded AGPH to a newly created "Absoute-Must-Buy-NOW-Invest-Everything-Mortgage-The-Farm-Widows-And-Orphans-Included" rating.
In a Barrons report after the bell, no mention was made of the cure for cancer or the common cold. However, Barrons reported that the clinical HIV data failed to consider two cases of mild diarrea that someone told them about a few weeks ago. Additionally, they predicted that the absence of tax credits for losses carried forward could potentially hold AGPH earnings to around $1500 per share by the year 2025.
Largely in response to the Barron's article, AGPH shares sold off in after hours trading by 27 1/2, closing at 18 3/4 on heavy volume.
And you all thought John W was paranoid!!!
Tom |
